Statistics for A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Total visits
views | |
---|---|
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782) | 2 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 1 |
April 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:95ee9d32-76f7-4db6-9c64-0585ba61269e | 17 |
java.util.UUID:95408b96-fcb6-41e4-9c43-be898d0563c0 | 14 |
Leal2022Phase-CCBY.pdf | 6 |
java.util.UUID:d7fb7e15-2065-4504-8876-b0385a00dfba | 6 |
Top country views
views | |
---|---|
United States | 2 |
Top city views
views | |
---|---|
Franklin | 1 |
Mooresville | 1 |